Tag Archives: treat
Big time losers and the reasons why (TRGT, XIDE, AMLN)
In this report: Targacept Inc. (NASDAQ:TRGT), Exide Technologies (NASDAQ:XIDE) and Amylin Pharmaceuticals (NASDAQ:AMLN).
Targacept Inc. (NASDAQ:TRGT) has dropped by over 56 percent today after the company announced that its experimental drug TC-5214 failed to meet expectations in a trial to …
Posted in Main Post, Reports
|
Tagged AMLN, Amylin Pharmaceuticals, clinical trial, company, diabetes, drug, Eli Lilly and Co (NYSE:LLY), Exide Technologies, expectations, fiscal, guidance, NASDAQ, NASDAQ:AMLN, NASDAQ:TRGT, NASDAQ:XIDE, net sales, operating income, partnership, patients, payments, Phase 3, preliminary, products, quarter, results, revenue, severe depression, Targacept Inc., therapy, treat, TRGT, trial, XIDA
|
Comments Off
















